• Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

  • Sep 13 2024
  • Length: 1 hr and 1 min
  • Podcast

Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

  • Summary

  • Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.